Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

BRIUMVI under the microscope: Real-World MS registry launches

NCT ID NCT06433752

Knowledge-focused Sponsor: TG Therapeutics, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 01, 2026 · Updated 4 times

Summary

This registry study will follow 2000 people with relapsing multiple sclerosis who are prescribed BRIUMVI (ublituximab-xiiy) in real-world settings. Researchers aim to track safety, effectiveness (like relapse rates), and the overall treatment experience. Participants must not have received BRIUMVI before and will be observed during their routine care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BRIUMVI (ublituximab-xiiy)
What this could lead to
If successful, this study could provide real-world evidence on how well BRIUMVI works and its safety in everyday clinical practice for people with relapsing multiple sclerosis.
What could go wrong
This is an observational registry, not a controlled trial, so results may be influenced by factors like patient differences or treatment patterns. It does not test a new treatment but gathers data on an existing one.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Apr 2032

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will include participants with RMS who are receiving BRIUMVI® (ublituximab-xiiy).

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Confirmed Multiple Sclerosis (MS) diagnosis. 2. Participants who have not received any BRIUMVI® (ublituximab-xiiy) infusion prior to study start. Participants who have been prescribed BRIUMVI® (ublituximab-xiiy) but have not yet received their first infusion on Day 1 of 150 milligrams (mg) can be included. Exclusion Criteria: 1. Have received any live or live-attenuated vaccines (including for varicella-zoster virus or measles) within 4 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration or any non-live vaccines within 2 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration. 2. Any active infection (e.g., active Hepatitis B virus \[HBV\]) 3. Concurrent participation in any interventional MS trials, or planned concurrent treatment with other Multiple Sclerosis Disease Modifying Therapy (MS DMT) during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

multiple sclerosis relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis Relapsing multiple sclerosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    109 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Birmingham, Alabama, 35209, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Cullman, Alabama, 35058, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Huntsville, Alabama, 35802, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Mobile, Alabama, 36604, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Gilbert, Arizona, 85297, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Phoenix, Arizona, 85032, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Scottsdale, Arizona, 85253, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Fresno, California, 93720, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Newport Beach, California, 92663, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Orange, California, 68130, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    West Hollywood, California, 90048, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Aurora, Colorado, 80045, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Basalt, Colorado, 81621, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Colorado Springs, Colorado, 80918, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Colorado Springs, Colorado, 80920, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Denver, Colorado, 80222, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Fort Collins, Colorado, 80528, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Grand Junction, Colorado, 81501, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Farmington, Connecticut, 06032, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Hartford, Connecticut, 06112, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Altamonte Springs, Florida, 32714, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Boca Raton, Florida, 33486, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Clearwater, Florida, 33761, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Gainesville, Florida, 32611, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Maitland, Florida, 32751, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Miami, Florida, 33176, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Naples, Florida, 34105, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Orlando, Florida, 32806, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Pensacola, Florida, 32504, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Weston, Florida, 33331, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Atlanta, Georgia, 30309, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Atlanta, Georgia, 30327, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Savannah, Georgia, 31406, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Smyrna, Georgia, 30080, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Honolulu, Hawaii, 96817, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Coeur d'Alene, Idaho, 83814, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Chicago, Illinois, 60611, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Chicago, Illinois, 60612, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Evanston, Illinois, 60201, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Urbana, Illinois, 61801, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Avon, Indiana, 46123, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Roeland Park, Kansas, 66205, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Lexington, Kentucky, 40504, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Louisville, Kentucky, 40202, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Baltimore, Maryland, 21237, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Glen Burnie, Maryland, 21061, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Burlington, Massachusetts, 01805, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Norfolk, Massachusetts, 02481, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Ann Arbor, Michigan, 48019, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Detroit, Michigan, 48202, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Farmington, Michigan, 48334, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Owosso, Michigan, 48867, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Rochester Hills, Michigan, 48307, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Golden Valley, Minnesota, 55422, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Plymouth, Minnesota, 55446, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Billings, Montana, 59101, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Omaha, Nebraska, 68154, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Las Vegas, Nevada, 89106, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Bridgewater, New Jersey, 08807, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Cherry Hill, New Jersey, 08002, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Freehold, New Jersey, 07728, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Livingston, New Jersey, 07039, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Neptune City, New Jersey, 00753, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Teaneck, New Jersey, 07666, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Amherst, New York, 14226, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    New York, New York, 11501, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Charlotte, North Carolina, 28210, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    New Bern, North Carolina, 28562, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Raleigh, North Carolina, 27607, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Centerville, Ohio, 45429, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Centerville, Ohio, 45459, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Cincinnati, Ohio, 45212, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Cleveland, Ohio, 44195, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Columbus, Ohio, 43214, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Columbus, Ohio, 43235, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Toledo, Ohio, 43608, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Norman, Oklahoma, 73019, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Portland, Oregon, 97225, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Bethlehem, Pennsylvania, 18017, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Franklin, Tennessee, 37067, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Knoxville, Tennessee, 37996, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Mount Juliet, Tennessee, 37122, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Nashville, Tennessee, 37215, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Spring Hill, Tennessee, 37174, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Austin, Texas, 78712, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Austin, Texas, 78723, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Austin, Texas, 78758, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Dallas, Texas, 75206, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Dallas, Texas, 75243, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Edinburg, Texas, 78572, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Frisco, Texas, 75035, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Lubbock, Texas, 79414, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    San Antonio, Texas, 78229, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Ogden, Utah, 84403, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Salt Lake City, Utah, 84103, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Smith, Utah, 84148, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Charlottesville, Virginia, 22908, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Salem, Virginia, 24153, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Vienna, Virginia, 22182, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Virginia Beach, Virginia, 23456, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Kirkland, Washington, 98034, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Morgantown, West Virginia, 26506, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Greenfield, Wisconsin, 53228, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Neenah, Wisconsin, 54956, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Waukesha, Wisconsin, 53188, United States

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Guaynabo, 00968, Puerto Rico

More trials for these conditions

Other studies related to the condition(s) this trial covers.